1. α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways.

Publication Work Type

Research Paper

Publisher Name

Springer Nature

Magazine \ Newspaper

BMC Cardiovascular Disorders

more of publication

Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway

by Sarah M. AL-Qabbaa , Samaher I. Qaboli , Tahani K. Alshammari , Maha A. Alamin , Haya M. Alrajeh , Lama A. Almuthnabi , Rana R. Alotaibi , Asma S. Alonazi , Anfal F. Bin Dayel , Nawal M. Alrasheed a

2023

Published in:

MDPI

1. α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways.

by Nawal M. Alrasheed, Raghad B. Alammari, Tahani K. Alshammari, Maha A. Alamin, Abeer O. Alharbi, Asma S. Alonazi, Anfal F. Bin Dayel and Nouf M. Alrasheed.

2023

Published in:

Springer Nature

Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms?

2013

Dr. Maha Abdulrahman AL-Amin Ali

1. α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways.